EXHIBIT 4.1 RIGHTS AGREEMENT dated as of / /, 2003Rights Agreement • December 11th, 2003 • Bioveris Corp • Laboratory analytical instruments • Delaware
Contract Type FiledDecember 11th, 2003 Company Industry Jurisdiction
EXHIBIT 4 RIGHTS AGREEMENT dated as of January 9, 2004Rights Agreement • February 10th, 2004 • Bioveris Corp • Laboratory analytical instruments • Delaware
Contract Type FiledFebruary 10th, 2004 Company Industry Jurisdiction
WITNESSETH:Indemnification Agreement • November 12th, 2003 • Bioveris Corp • Laboratory analytical instruments • Delaware
Contract Type FiledNovember 12th, 2003 Company Industry Jurisdiction
LEASE AGREEMENTLease Agreement • November 6th, 2006 • Bioveris Corp • Laboratory analytical instruments
Contract Type FiledNovember 6th, 2006 Company IndustryTHIS LEASE AGREEMENT is made as of this day of September, 2006, between ARE-MARYLAND NO. 23, LLC, a Delaware limited liability company (“Landlord”), and BIOVERIS CORPORATION, a Delaware corporation (“Tenant”).
AMENDED AND RESTATED STOCKHOLDERS AGREEMENTStockholders Agreement • May 3rd, 2007 • Bioveris Corp • Laboratory analytical instruments
Contract Type FiledMay 3rd, 2007 Company IndustryAGREEMENT, dated as of May 2, 2007 and effective as of April 4, 2007, among Roche Holding Ltd, a joint stock company organized under the laws of Switzerland (“Parent”), and the stockholders of BioVeris Corporation, a Delaware corporation (the “Company”), that are parties hereto (each, a “Stockholder” and, collectively, the “Stockholders”).
AGREEMENT AND PLAN OF MERGERMerger Agreement • April 10th, 2007 • Bioveris Corp • Laboratory analytical instruments • Delaware
Contract Type FiledApril 10th, 2007 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated as of April 4, 2007 (this "Agreement"), is among Roche Holding Ltd, a joint stock company organized under the laws of Switzerland ("Parent"), Lili Acquisition Corporation, a newly-formed Delaware corporation and an indirect wholly-owned Subsidiary of Parent ("Merger Sub"), and BioVeris Corporation, a Delaware corporation (the "Company"). Certain capitalized terms used in this Agreement are as defined in this Agreement.
Exhibit 10.33 EQUITY RIGHT PURCHASE AND LICENSE AMENDMENT AGREEMENT THIS EQUITY RIGHT PURCHASE AND LICENSE AMENDMENT AGREEMENT ("Agreement") is entered into December 30, 2003 ("Effective Date") by and between IGEN International, Inc. ("IGEN"), and...Equity Right Purchase and License Amendment Agreement • December 30th, 2003 • Bioveris Corp • Laboratory analytical instruments • Delaware
Contract Type FiledDecember 30th, 2003 Company Industry Jurisdiction
LICENSE AGREEMENTLicense Agreement • April 10th, 2007 • Bioveris Corp • Laboratory analytical instruments • New York
Contract Type FiledApril 10th, 2007 Company Industry JurisdictionTHIS LICENSE AGREEMENT (the “Agreement”) is made as of the _____ day of April, 2007, by and between BioVeris Corporation (“BioVeris”), a Delaware corporation having a principal place of business at 16020 Industrial Drive, Gaithersburg, Maryland 20877, United States of America, and 32 Mott Street Acquisition II, LLC (“Newco”), a Delaware limited liability company having offices at __________________________________, with reference to the following facts:
ECL ASSET TRANSFER AGREEMENT Dated as of April 4, 2007 between BIOVERIS CORPORATION and 32 MOTT STREET ACQUISITION II, LLCAsset Transfer Agreement • April 10th, 2007 • Bioveris Corp • Laboratory analytical instruments • Delaware
Contract Type FiledApril 10th, 2007 Company Industry JurisdictionThis ECL ASSET TRANSFER AGREEMENT (this ECL Asset Transfer Agreement, together with all annexes, exhibits, schedules and other documents attached hereto, hereinafter referred to as the “Agreement”) dated as of April 4, 2007 is made by and between BioVeris Corporation, a Delaware corporation (“Seller”), and 32 Mott Street Acquisition II, LLC, a Delaware limited liability company (“Purchaser”).
AGREEMENTAgreement • August 16th, 2004 • Bioveris Corp • Laboratory analytical instruments • Delaware
Contract Type FiledAugust 16th, 2004 Company Industry JurisdictionWHEREAS, BioVeris Corporation (“BioVeris”) has not yet filed its annual report on Form 10-K for the fiscal year ending on March 31, 2004 (“Form 10-K”);
IGEN International, Inc.Services Agreement • August 16th, 2004 • Bioveris Corp • Laboratory analytical instruments • Maryland
Contract Type FiledAugust 16th, 2004 Company Industry JurisdictionWellstat Therapeutics Corporation Wellstat Biologics Corporation Hyperion Catalysis International Corporation Proteinix, Inc. Integrated Chemical Synthesizers, Inc.
TRANSACTION AGREEMENTTransaction Agreement • April 10th, 2007 • Bioveris Corp • Laboratory analytical instruments • Delaware
Contract Type FiledApril 10th, 2007 Company Industry JurisdictionThis TRANSACTION AGREEMENT, dated as of April 4, 2007 (this “Agreement”), is by and between Samuel J. Wohlstadter (the “Stockholder”) and Roche Holdings Ltd (“Roche”).
VACCINES ASSET TRANSFER AGREEMENT Dated as of April 4, 2007 between BIOVERIS CORPORATION and 32 MOTT STREET ACQUISITION I, LLCVaccines Asset Transfer Agreement • April 10th, 2007 • Bioveris Corp • Laboratory analytical instruments • Delaware
Contract Type FiledApril 10th, 2007 Company Industry JurisdictionThis VACCINES ASSET TRANSFER AGREEMENT (this Vaccines Asset Transfer Agreement, together with all annexes, exhibits, schedules and other documents attached hereto, hereinafter referred to as the “Agreement”) dated as of April 4, 2007 is made by and between BioVeris Corporation, a Delaware corporation (“Seller”), and 32 Mott Street Acquisition I, LLC, a Delaware limited liability company (“Purchaser”).
ECL SETTLEMENT AGREEMENTSettlement Agreement • November 6th, 2006 • Bioveris Corp • Laboratory analytical instruments
Contract Type FiledNovember 6th, 2006 Company IndustryThis Settlement Agreement (this “Agreement”), dated September 15, 2006 (the “Effective Date”) is made and entered into by and among bioMérieux, Inc. and bioMérieux bv (collectively, “bioMerieux”) and BioVeris Corporation (“BioVeris”).
NON-DISCLOSURE AND NON-SOLICITATION AGREEMENTNon-Disclosure and Non-Solicitation Agreement • April 10th, 2007 • Bioveris Corp • Laboratory analytical instruments
Contract Type FiledApril 10th, 2007 Company IndustryThis Non-Disclosure and Non-Solicitation Agreement (this “Agreement”) is made this 4th day of April 2007, by and between BioVeris Corporation, its present and former subsidiaries, affiliated divisions and companies, successors, and assigns (collectively, “BioVeris”) and Samuel J. Wohlstadter (“SJW”). BioVeris and SJW may hereinafter be referred to individually as a “Party” and collectively as the “Parties.”
AMENDMENT NO. 1 TO THE RIGHTS AGREEMENTRights Agreement • April 6th, 2007 • Bioveris Corp • Laboratory analytical instruments • Delaware
Contract Type FiledApril 6th, 2007 Company Industry JurisdictionTHIS AMENDMENT NO. 1 dated April 4, 2007 (this “Amendment”), amends the Rights Agreement, dated as of January 9, 2004 (the “Rights Agreement”), by and between BioVeris Corporation, a Delaware corporation (the “Company”), and Computershare Trust Company, N.A. (formerly EquiServe Trust Company, N.A.), as rights agent (the “Rights Agent”). All capitalized terms used but not defined in this Amendment shall have the meanings ascribed to them in the Rights Agreement.
LEASE AGREEMENTLease Agreement • July 7th, 2005 • Bioveris Corp • Laboratory analytical instruments • Maryland
Contract Type FiledJuly 7th, 2005 Company Industry JurisdictionPREMISES: Approximately 112,318 rentable square feet of a certain portion of the building located at 16050 Industrial Drive Gaithersburg, MD